← Search

Excel · study · 2026

MiR-30d-5p modulation induces expression changes related to β-cell function, survival and regeneration

Listed in NCBI GEO

Type 1 diabetes is an autoimmune disease characterized by the destruction of insulin-producing β-cells, leading to hyperglycemia.

Description

A temporary partial remission (PR) phase often follows diagnosis, marked by improved glycemic control and reduced autoimmunity. This study investigates the role of miR-30d-5p, a microRNA highly expressed during PR, on beta-cell recovery and regeneration.

Remarkably, human pancreatic slices were successfully transfected with oligonucleotides (miR-30d-5p inhibitor or mimic), enabling exploration of post-transcriptional regulation in a human context. Bulk RNA sequencing on human pancreatic slices from 3 non-diabetic donors confirmed the regulation of gene networks linked to both β-cell function and regeneration. PCA revealed clustering by donor, indicating strong inter-donor variability; this was corrected using ComBat, allowing clearer separation of treatment groups.

Read the rest (2 more)

Differential expression analysis identified 273 DEGs for miR-30d-5p inhibition, 518 for overexpression, and 480 between the two treatments. Key gene changes reflected biological roles aligned with the miRNA’s proposed regulatory function: inhibition of miR-30d-5p upregulated genes linked to stress, immune activation, and metabolism (e.g., GLUT6, TGFB3, CYP4F8), while overexpression enhanced β-cell function and insulin secretion genes (e.g., HOOK1, ISL1, TTR, CACNB3).

GO analysis showed that miR-30d-5p inhibition enriched pathways related to protein stress and impaired differentiation, whereas overexpression activated processes involved in ion homeostasis, morphogenesis, and β-cell maintenance. Transcription factor analysis highlighted FOXO3, NOTCH3, JUND, and NR1H2 as potential regulators. Overall, miR-30d-5p promotes β-cell survival, insulin synthesis, and immunoregulation.

Links

Topics

From keywords
Life Sciences
Inferred from text
Disease 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE31680115 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:diseaseenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title